| Doxorubicin—an agent with multiple mechanisms of anticancer activity M Kciuk, A Gielecińska, S Mujwar, D Kołat, Ż Kałuzińska-Kołat, I Celik, ... Cells 12 (4), 659, 2023 | 278 | 2023 |
| A retrospect on antimicrobial potential of thiazole scaffold I Mishra, R Mishra, S Mujwar, P Chandra, N Sachan Journal of Heterocyclic Chemistry 57 (6), 2304-2329, 2020 | 76 | 2020 |
| Targeting carbonic anhydrase IX and XII isoforms with small molecule inhibitors and monoclonal antibodies M Kciuk, A Gielecińska, S Mujwar, M Mojzych, B Marciniak, R Drozda, ... Journal of Enzyme Inhibition and Medicinal Chemistry 37 (1), 1278-1298, 2022 | 75 | 2022 |
| Repurposing metocurine as main protease inhibitor to develop novel antiviral therapy for COVID-19 R Jain, S Mujwar Structural chemistry 31 (6), 2487-2499, 2020 | 73 | 2020 |
| Cyclin-dependent kinases in DNA damage response M Kciuk, A Gielecińska, S Mujwar, M Mojzych, R Kontek Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1877 (3), 188716, 2022 | 72 | 2022 |
| Molecular Docking and In Silico Cogitation Validate Mefenamic Acid Prodrugs as Human Cyclooxygenase-2 Inhibitor PM Kamal Shah, Somdutt Mujwar, Jeetendra Kumar Gupta, Sushant K. Shrivastava ASSAY and Drug Development Technologies 17 (6), 2019 | 65 | 2019 |
| Computational repurposing of tamibarotene against triple mutant variant of SARS-CoV-2 S Mujwar Computers in Biology and Medicine 136, 104748, 2021 | 60 | 2021 |
| Prediction of Riboswitch as a potential drug target for infectious diseases: An Insilico case study of anthrax S Mujwar, KR Pardasani Journal of Medical Imaging and Health Informatics 5 (1), 7-16, 2015 | 56 | 2015 |
| Drug Repurposing Approach for Developing Novel Therapy Against Mupirocin-Resistant Staphylococcus aureus S Mujwar, R Deshmukh, RK Harwansh, JK Gupta, A and Gour ASSAY and Drug Development Technologies 17 (7), 298-309, 2019 | 49 | 2019 |
| A review on natural antioxidants for their role in the treatment of Parkinson’s disease P Mittal, S Dhankhar, S Chauhan, N Garg, T Bhattacharya, M Ali, ... Pharmaceuticals 16 (7), 908, 2023 | 47 | 2023 |
| Impact of diabetes on male sexual function in streptozotocin-induced diabetic rats: Protective role of soluble epoxide hydrolase inhibitor N Minaz, R Razdan, BD Hammock, S Mujwar, SK Goswami Biomedicine & Pharmacotherapy 115, 108897, 2019 | 47 | 2019 |
| In silico evaluation of food‐derived carotenoids against SARS‐CoV‐2 drug targets: Crocin is a promising dietary supplement candidate for COVID‐19 S Mujwar, L Sun, O Fidan Journal of Food Biochemistry 46 (9), e14219, 2022 | 45 | 2022 |
| Computational drug repurposing approach to identify potential fatty acid-binding protein-4 inhibitors to develop novel antiobesity therapy S Mujwar, V Kumar Assay and Drug Development Technologies 18 (7), 318-327, 2020 | 43 | 2020 |
| Prediction of riboswitch as a potential drug target and design of its optimal inhibitors for Mycobacterium tuberculosis S Mujwar, KR Pardasani International Journal of Computational Biology and Drug Design 8 (4), 326-347, 2015 | 42 | 2015 |
| Repurposing benzbromarone as antifolate to develop novel antifungal therapy for Candida albicans S Mujwar, A Tripathi Journal of Molecular Modeling 28 (7), 193, 2022 | 41 | 2022 |
| Discovery of adapalene and dihydrotachysterol as antiviral agents for the Omicron variant of SARS-CoV-2 through computational drug repurposing O Fidan, S Mujwar, M Kciuk Molecular diversity 27 (1), 463-475, 2023 | 39 | 2023 |
| Preparation of Novel Pyrazolo[4,3-e]tetrazolo[1,5-b][1,2,4]triazine Sulfonamides and Their Experimental and Computational Biological Studies M Kciuk, S Mujwar, A Szymanowska, B Marciniak, K Bukowski, M Mojzych, ... International Journal of Molecular Sciences 23 (11), 5892, 2022 | 39 | 2022 |
| Molecular docking based analysis to elucidate the DNA topoisomerase IIβ as the potential target for the ganoderic acid; a natural therapeutic agent in cancer therapy KK Sharma, B Singh, S Mujwar, PS Bisen Current computer-aided drug design 16 (2), 176-189, 2020 | 39 | 2020 |
| In silico bioprospecting of taraxerol as a main protease inhibitor of SARS-CoV-2 to develop therapy against COVID-19 S Mujwar, RK Harwansh Structural Chemistry 33 (5), 1517-1528, 2022 | 37 | 2022 |
| Insilico Analysis of Dietary Agents as Anticancer Inhibitors of Insulin Like Growth Factor 1 Receptor (IGF1R) N Soni, KR Pardasani, S Mujwar International Journal of Pharmacy and Pharmaceutical Sciences 7 (9), 191-196, 2015 | 36 | 2015 |
Mateusz KciukUniwersytet Łódzkiunilodz.eu의 이메일 확인됨
